Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 5/20 | 0.38 |
| ▸ | HTR1A | P08908 | 4/20 | 0.38 |
| ▸ | HTR1B | P28222 | 4/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | DRD2 | P14416 | 4/20 | 0.38 |
| ▸ | DRD3 | P35462 | 4/20 | 0.38 |
| ▸ | DRD4 | P21917 | 3/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15959683 | 1.00 | HTR1D (0.38) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL17792922 | 0.95 | CHRM1 (0.37) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL15959681 | 0.94 | HTR1D (0.35) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL17933198 | 0.85 | CHRM1 (0.36) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL2810467 | 0.84 | HTR1D (0.47) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL1702438 | 0.84 | HTR1D (0.47) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL17548705 | 0.84 | HTR1D (0.47) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL29511664 | 0.84 | HTR1D (0.47) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL10023272 | 0.84 | HTR1D (0.47) | HTR1DHTR1AHTR1BCHRM1DRD2 | |
| SCHEMBL17922761 | 0.81 | DRD2 (0.39) | HTR1DHTR1AHTR1BCHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | NR2E1, NR0B1, NR2E3 | HTR1D 1223/4885HTR1A 1705/4885HTR1B 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.